United States Healthcare Equipment & Supplies

OrthoPediatrics Corp (KIDS)

Track

Track

OrthoPediatrics Corp experienced significant insider trading activity on March 16, 2026. Multiple executives, including the CEO and CFO, executed sales and proposed divestments of company shares. These transactions represent the most recent recorded movements, occurring well over three months ago. No further buying or selling patterns have emerged since that date.
Ticker: KIDS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for OrthoPediatrics Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Hauser Joseph W Pres. Trauma & Def. Correction Officer
Transaction date
Sale
Price
29.56
Quantity 24,694 +44.3%
Value US$1,149,725
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
138.01
Quantity 77,026 +9.5%
Value US$3,854,044
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Sale
Price
412.06
Quantity 87,036 -39.9%
Value US$1,797,581
2.6
Bailey David R President and CEO Executive Director
Transaction date
Sale
Price
17.25
Quantity 19,535 -6.2%
Value US$336,979
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
17.25
Quantity 8,614 -5.4%
Value US$148,592
3.1
Odle Gregory A Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 8,433
Value US$145,506
2.2
Hite Fred Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 12,993
Value US$224,186
2.9
Hauser Joseph W Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 8,596
Value US$148,319
3.3
Gerritzen Daniel J Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 8,614
Value US$148,629
2.6
Bailey David R Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 19,535
Value US$337,065
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Purchase
Price
19.41
Quantity 5,076 +2.4%
Value US$98,525
2.6
Bailey David R President and CEO Executive Director
Transaction date
Sale
Price
24.86
Quantity 6,620 -2.0%
Value US$164,573
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
24.86
Quantity 5,310 -4.6%
Value US$132,007
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Sale
Price
24.86
Quantity 5,359 -3.5%
Value US$133,225
2.9
Hauser Joseph W Pres. Trauma & Def. Correction Officer
Transaction date
Sale
Price
24.86
Quantity 5,300 -3.7%
Value US$131,758
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
24.86
Quantity 6,443 -3.0%
Value US$160,173
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
29.30
Quantity 10,000 -11.5%
Value US$293,000
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
27.59
Quantity 3,195 -3.3%
Value US$88,150
2.5
Throdahl Mark C Non-Executive Director
Transaction date
Sale
Price
27.59
Quantity 2,433 -1.7%
Value US$67,126
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
27.59
Quantity 2,741 -5.0%
Value US$75,624
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Sale
Price
27.59
Quantity 2,768 -3.3%
Value US$76,369
2.6
Bailey David R President and CEO Executive Director
Transaction date
Sale
Price
27.59
Quantity 3,213 -2.3%
Value US$88,647
2.9
Hauser Joseph W Pres. Trauma & Def. Correction Officer
Transaction date
Sale
Price
28.06
Quantity 2,903 -5.2%
Value US$81,458
3.0
Schlotterback Terry D Non-Executive Director
Transaction date
Sale
Price
38.25
Quantity 2,610 -14.5%
Value US$99,832
3.0
Schlotterback Terry D Director Non-Executive Director
Transaction date
Proposed sale
Price
38.02
Quantity 2,610
Value US$99,238
2.2
Hite Fred Officer; Director, CFO & COO Executive Director
Transaction date
Proposed sale
Price
43.87
Quantity 4,356
Value US$191,098
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
43.69
Quantity 4,356 -4.3%
Value US$190,304
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Planned sale
Price
50.10
Quantity 3,333 -3.8%
Value US$166,969
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Planned sale
Price
50.02
Quantity 828 -0.9%
Value US$41,420
3.1
Odle Gregory A President of Scoliosis Officer
Transaction date
Planned sale
Price
50.02
Quantity 644 -0.7%
Value US$32,212
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Sale
Price
44.03
Quantity 3,421 -4.8%
Value US$150,618
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
43.77
Quantity 4,099 -5.4%
Value US$179,397
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
44.62
Quantity 3,315 -8.5%
Value US$147,916
2.5
Throdahl Mark C Non-Executive Director
Transaction date
Sale
Price
43.83
Quantity 4,515 -3.4%
Value US$197,872
2.6
Bailey David R President and CEO Executive Director
Transaction date
Sale
Price
44.40
Quantity 4,052 -3.9%
Value US$179,910
2.9
Hauser Joseph W Sr VP & GM Trauma & Deformity Officer
Transaction date
Sale
Price
43.74
Quantity 2,554 -6.6%
Value US$111,705
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Planned sale
Price
50.00
Quantity 1,195 -1.6%
Value US$59,754
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Planned sale
Price
47.00
Quantity 80 -0.1%
Value US$3,760
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Planned sale
Price
45.00
Quantity 1,771 -2.4%
Value US$79,695
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Planned sale
Price
45.04
Quantity 229 -0.3%
Value US$10,315
3.6
Ruf Harold Non-Executive Director
Transaction date
Purchase
Price
39.45
Quantity 1,235 +9.8%
Value US$48,721
2.6
Bailey David R President and CEO Executive Director
Transaction date
Sale
Price
58.10
Quantity 4,078 -4.3%
Value US$236,932
2.5
Throdahl Mark C Non-Executive Director
Transaction date
Sale
Price
58.60
Quantity 5,961 -4.6%
Value US$349,315
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Sale
Price
57.55
Quantity 4,108 -6.1%
Value US$236,415
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
58.46
Quantity 3,918 -12.7%
Value US$229,046
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
57.48
Quantity 4,919 -7.5%
Value US$282,744
2.9
Hauser Joseph W Sr VP & GM Trauma & Deformity Officer
Transaction date
Sale
Price
46.04
Quantity 3,220 -10.8%
Value US$148,249
3.3
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
58.26
Quantity 500 +241.5%
Value US$29,130
3.3
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
60.36
Quantity 500 +62.5%
Value US$30,180
3.3
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
60.24
Quantity 500 +62.5%
Value US$30,120
3.3
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
60.42
Quantity 1,000 +10.1%
Value US$60,420
3.2
Pelizzon David R Non-Executive Director
Transaction date
Purchase
Price
66.48
Quantity 825 +3.7%
Value US$54,846
2.8
Berry Bernie B III Non-Executive Director
Transaction date
Planned sale
Price
66.60
Quantity 2,000 -7.8%
Value US$133,200
2.8
Berry Bernie B III Non-Executive Director
Transaction date
Sale
Price
64.54
Quantity 300 -1.2%
Value US$19,362
3.3
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
56.14
Quantity 500 +inf%
Value US$28,070
3.3
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
56.13
Quantity 500 +inf%
Value US$28,065
3.3
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
55.89
Quantity 500 +inf%
Value US$27,945
3.3
Pritzker Jennifer N. Large shareholder
Transaction date
Purchase
Price
57.49
Quantity 1,500 +18.8%
Value US$86,235
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
63.03
Quantity 4,000 -11.5%
Value US$252,120
2.8
Berry Bernie B III Non-Executive Director
Transaction date
Planned sale
Price
60.00
Quantity 3,209 -11.6%
Value US$192,540
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Planned sale
Price
60.20
Quantity 3,750 -5.3%
Value US$225,750
2.8
Berry Bernie B III Non-Executive Director
Transaction date
Planned sale
Price
60.15
Quantity 4,791 -14.8%
Value US$288,179
1.8
Infante (Reynolds) Marie C Non-Executive Director
Transaction date
Sale
Price
45.78
Quantity 700 -15.2%
Value US$32,046
3.2
Pelizzon David R Non-Executive Director
Transaction date
Purchase
Price
46.50
Quantity 3,700 +21.5%
Value US$172,050
3.6
Ruf Harold Non-Executive Director
Transaction date
Purchase
Price
46.98
Quantity 2,880 +18.3%
Value US$135,302
3.3
Gerritzen Daniel J General Counsel and Secretary Officer
Transaction date
Sale
Price
55.85
Quantity 2,633 -8.3%
Value US$147,053
2.2
Hite Fred COO and CFO Executive Director
Transaction date
Sale
Price
55.87
Quantity 4,310 -6.3%
Value US$240,800
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Sale
Price
55.88
Quantity 8,193 -11.3%
Value US$457,825
2.6
Bailey David R President Officer
Transaction date
Sale
Price
55.84
Quantity 4,769 -5.1%
Value US$266,301
2.5
Throdahl Mark C CEO Executive Director
Transaction date
Sale
Price
55.88
Quantity 5,097 -3.4%
Value US$284,820
2.8
Berry Bernie B III Non-Executive Director
Transaction date
Planned sale
Price
57.00
Quantity 699 -2.1%
Value US$39,843
2.8
Berry Bernie B III Non-Executive Director
Transaction date
Planned sale
Price
57.09
Quantity 1,600 -4.6%
Value US$91,344
2.8
Berry Bernie B III Non-Executive Director
Transaction date
Planned sale
Price
57.16
Quantity 1,701 -4.7%
Value US$97,229
3.1
Odle Gregory A Executive Vice President Officer
Transaction date
Planned sale
Price
56.50
Quantity 3,750 -4.9%
Value US$211,875
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-17 2026-03-16 S Sale
2.9
Hauser Joseph W

Pres. Trauma & Def. Correction

Officer
24,694 +44.3%
29.56
US$1,149,725 		24,694 +44.3% 29.56 US$1,149,725
2026-03-17 2026-03-16 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
77,026 +9.5%
138.01
US$3,854,044 		77,026 +9.5% 138.01 US$3,854,044
2026-03-17 2026-03-16 S Sale
3.1
Odle Gregory A

President of Scoliosis

Officer
87,036 -39.9%
412.06
US$1,797,581 		87,036 -39.9% 412.06 US$1,797,581
2026-03-17 2026-03-16 S Sale
2.6
Bailey David R

President and CEO

Executive Director
19,535 -6.2%
17.25
US$336,979 		19,535 -6.2% 17.25 US$336,979
2026-03-17 2026-03-16 S Sale
3.3
Gerritzen Daniel J

General Counsel and Secretary

Officer
8,614 -5.4%
17.25
US$148,592 		8,614 -5.4% 17.25 US$148,592
2026-03-16 2026-03-16 PrS Proposed sale
3.1
Odle Gregory A

Officer

Officer
8,433
17.25
US$145,506 		8,433 17.25 US$145,506
2026-03-16 2026-03-16 PrS Proposed sale
2.2
Hite Fred

Officer

Officer
12,993
17.25
US$224,186 		12,993 17.25 US$224,186
2026-03-16 2026-03-16 PrS Proposed sale
2.9
Hauser Joseph W

Officer

Officer
8,596
17.25
US$148,319 		8,596 17.25 US$148,319
2026-03-16 2026-03-16 PrS Proposed sale
3.3
Gerritzen Daniel J

Officer

Officer
8,614
17.25
US$148,629 		8,614 17.25 US$148,629
2026-03-16 2026-03-16 PrS Proposed sale
2.6
Bailey David R

Officer

Officer
19,535
17.25
US$337,065 		19,535 17.25 US$337,065
2025-08-25 2025-08-21 B Purchase
2.2
Hite Fred

COO and CFO

Executive Director
5,076 +2.4%
19.41
US$98,525 		5,076 +2.4% 19.41 US$98,525
2025-03-18 2025-03-18 S Sale
2.6
Bailey David R

President and CEO

Executive Director
6,620 -2.0%
24.86
US$164,573 		6,620 -2.0% 24.86 US$164,573
2025-03-18 2025-03-18 S Sale
3.3
Gerritzen Daniel J

General Counsel and Secretary

Officer
5,310 -4.6%
24.86
US$132,007 		5,310 -4.6% 24.86 US$132,007
2025-03-18 2025-03-18 S Sale
3.1
Odle Gregory A

President of Scoliosis

Officer
5,359 -3.5%
24.86
US$133,225 		5,359 -3.5% 24.86 US$133,225
2025-03-18 2025-03-18 S Sale
2.9
Hauser Joseph W

Pres. Trauma & Def. Correction

Officer
5,300 -3.7%
24.86
US$131,758 		5,300 -3.7% 24.86 US$131,758
2025-03-18 2025-03-18 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
6,443 -3.0%
24.86
US$160,173 		6,443 -3.0% 24.86 US$160,173
2024-08-22 2024-08-21 S Sale
3.3
Gerritzen Daniel J

General Counsel and Secretary

Officer
10,000 -11.5%
29.30
US$293,000 		10,000 -11.5% 29.30 US$293,000
2024-03-12 2024-03-11 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
3,195 -3.3%
27.59
US$88,150 		3,195 -3.3% 27.59 US$88,150
2024-03-12 2024-03-11 S Sale
2.5
Throdahl Mark C
Non-Executive Director
2,433 -1.7%
27.59
US$67,126 		2,433 -1.7% 27.59 US$67,126
2024-03-12 2024-03-11 S Sale
3.3
Gerritzen Daniel J

General Counsel and Secretary

Officer
2,741 -5.0%
27.59
US$75,624 		2,741 -5.0% 27.59 US$75,624
2024-03-12 2024-03-11 S Sale
3.1
Odle Gregory A

President of Scoliosis

Officer
2,768 -3.3%
27.59
US$76,369 		2,768 -3.3% 27.59 US$76,369
2024-03-12 2024-03-11 S Sale
2.6
Bailey David R

President and CEO

Executive Director
3,213 -2.3%
27.59
US$88,647 		3,213 -2.3% 27.59 US$88,647
2024-02-23 2024-02-22 S Sale
2.9
Hauser Joseph W

Pres. Trauma & Def. Correction

Officer
2,903 -5.2%
28.06
US$81,458 		2,903 -5.2% 28.06 US$81,458
2023-08-14 2023-08-11 S Sale
3.0
Schlotterback Terry D
Non-Executive Director
2,610 -14.5%
38.25
US$99,832 		2,610 -14.5% 38.25 US$99,832
2023-08-11 2023-08-11 PrS Proposed sale
3.0
Schlotterback Terry D

Director

Non-Executive Director
2,610
38.02
US$99,238 		2,610 38.02 US$99,238
2023-06-26 2023-06-26 PrS Proposed sale
2.2
Hite Fred

Officer; Director, CFO & COO

Executive Director
4,356
43.87
US$191,098 		4,356 43.87 US$191,098
2023-06-26 2023-06-26 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
4,356 -4.3%
43.69
US$190,304 		4,356 -4.3% 43.69 US$190,304
2023-04-28 2023-04-27 PlS Planned sale
3.1
Odle Gregory A

President of Scoliosis

Officer
3,333 -3.8%
50.10
US$166,969 		3,333 -3.8% 50.10 US$166,969
2023-04-26 2023-04-25 PlS Planned sale
3.1
Odle Gregory A

President of Scoliosis

Officer
828 -0.9%
50.02
US$41,420 		828 -0.9% 50.02 US$41,420
2023-04-24 2023-04-21 PlS Planned sale
3.1
Odle Gregory A

President of Scoliosis

Officer
644 -0.7%
50.02
US$32,212 		644 -0.7% 50.02 US$32,212
2023-03-07 2023-03-06 S Sale
3.1
Odle Gregory A

Executive Vice President

Officer
3,421 -4.8%
44.03
US$150,618 		3,421 -4.8% 44.03 US$150,618
2023-03-07 2023-03-06 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
4,099 -5.4%
43.77
US$179,397 		4,099 -5.4% 43.77 US$179,397
2023-03-07 2023-03-06 S Sale
3.3
Gerritzen Daniel J

General Counsel and Secretary

Officer
3,315 -8.5%
44.62
US$147,916 		3,315 -8.5% 44.62 US$147,916
2023-03-07 2023-03-06 S Sale
2.5
Throdahl Mark C
Non-Executive Director
4,515 -3.4%
43.83
US$197,872 		4,515 -3.4% 43.83 US$197,872
2023-03-07 2023-03-06 S Sale
2.6
Bailey David R

President and CEO

Executive Director
4,052 -3.9%
44.40
US$179,910 		4,052 -3.9% 44.40 US$179,910
2023-03-06 2023-03-02 S Sale
2.9
Hauser Joseph W

Sr VP & GM Trauma & Deformity

Officer
2,554 -6.6%
43.74
US$111,705 		2,554 -6.6% 43.74 US$111,705
2023-02-03 2023-02-02 PlS Planned sale
3.1
Odle Gregory A

Executive Vice President

Officer
1,195 -1.6%
50.00
US$59,754 		1,195 -1.6% 50.00 US$59,754
2023-01-24 2023-01-20 PlS Planned sale
3.1
Odle Gregory A

Executive Vice President

Officer
80 -0.1%
47.00
US$3,760 		80 -0.1% 47.00 US$3,760
2023-01-17 2023-01-13 PlS Planned sale
3.1
Odle Gregory A

Executive Vice President

Officer
1,771 -2.4%
45.00
US$79,695 		1,771 -2.4% 45.00 US$79,695
2023-01-10 2023-01-09 PlS Planned sale
3.1
Odle Gregory A

Executive Vice President

Officer
229 -0.3%
45.04
US$10,315 		229 -0.3% 45.04 US$10,315
2022-06-16 2022-06-16 B Purchase
3.6
Ruf Harold
Non-Executive Director
1,235 +9.8%
39.45
US$48,721 		1,235 +9.8% 39.45 US$48,721
2022-03-03 2022-03-02 S Sale
2.6
Bailey David R

President and CEO

Executive Director
4,078 -4.3%
58.10
US$236,932 		4,078 -4.3% 58.10 US$236,932
2022-03-03 2022-03-02 S Sale
2.5
Throdahl Mark C
Non-Executive Director
5,961 -4.6%
58.60
US$349,315 		5,961 -4.6% 58.60 US$349,315
2022-03-03 2022-03-02 S Sale
3.1
Odle Gregory A

Executive Vice President

Officer
4,108 -6.1%
57.55
US$236,415 		4,108 -6.1% 57.55 US$236,415
2022-03-03 2022-03-02 S Sale
3.3
Gerritzen Daniel J

General Counsel and Secretary

Officer
3,918 -12.7%
58.46
US$229,046 		3,918 -12.7% 58.46 US$229,046
2022-03-03 2022-03-02 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
4,919 -7.5%
57.48
US$282,744 		4,919 -7.5% 57.48 US$282,744
2022-03-03 2022-02-07 S Sale
2.9
Hauser Joseph W

Sr VP & GM Trauma & Deformity

Officer
3,220 -10.8%
46.04
US$148,249 		3,220 -10.8% 46.04 US$148,249
2021-12-13 2021-12-10 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +241.5%
58.26
US$29,130 		500 +241.5% 58.26 US$29,130
2021-12-13 2021-12-09 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +62.5%
60.36
US$30,180 		500 +62.5% 60.36 US$30,180
2021-12-13 2021-12-09 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +62.5%
60.24
US$30,120 		500 +62.5% 60.24 US$30,120
2021-12-13 2021-12-09 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
1,000 +10.1%
60.42
US$60,420 		1,000 +10.1% 60.42 US$60,420
2021-11-12 2021-11-11 B Purchase
3.2
Pelizzon David R
Non-Executive Director
825 +3.7%
66.48
US$54,846 		825 +3.7% 66.48 US$54,846
2021-09-13 2021-09-07 S Sale
1.8
Infante (Reynolds) Marie C
Non-Executive Director
359 -6.8%
69.19
US$24,837 		359 -6.8% 69.19 US$24,837
2021-08-03 2021-08-02 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
2,000 -7.8%
66.60
US$133,200 		2,000 -7.8% 66.60 US$133,200
2021-06-16 2021-06-15 S Sale
2.8
Berry Bernie B III
Non-Executive Director
300 -1.2%
64.54
US$19,362 		300 -1.2% 64.54 US$19,362
2021-05-17 2021-05-13 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +inf%
56.14
US$28,070 		500 +inf% 56.14 US$28,070
2021-05-17 2021-05-13 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +inf%
56.13
US$28,065 		500 +inf% 56.13 US$28,065
2021-05-17 2021-05-13 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +inf%
55.89
US$27,945 		500 +inf% 55.89 US$27,945
2021-05-17 2021-05-13 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
1,500 +18.8%
57.49
US$86,235 		1,500 +18.8% 57.49 US$86,235
2021-05-12 2021-05-10 S Sale
3.3
Gerritzen Daniel J

General Counsel and Secretary

Officer
4,000 -11.5%
63.03
US$252,120 		4,000 -11.5% 63.03 US$252,120
2021-05-06 2021-05-06 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
3,209 -11.6%
60.00
US$192,540 		3,209 -11.6% 60.00 US$192,540
2021-05-04 2021-05-03 PlS Planned sale
3.1
Odle Gregory A

Executive Vice President

Officer
3,750 -5.3%
60.20
US$225,750 		3,750 -5.3% 60.20 US$225,750
2021-05-04 2021-05-03 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
4,791 -14.8%
60.15
US$288,179 		4,791 -14.8% 60.15 US$288,179
2021-03-17 2021-03-16 S Sale
1.8
Infante (Reynolds) Marie C
Non-Executive Director
700 -15.2%
45.78
US$32,046 		700 -15.2% 45.78 US$32,046
2021-03-17 2021-03-15 B Purchase
3.2
Pelizzon David R
Non-Executive Director
3,700 +21.5%
46.50
US$172,050 		3,700 +21.5% 46.50 US$172,050
2021-03-17 2021-03-15 B Purchase
3.6
Ruf Harold
Non-Executive Director
2,880 +18.3%
46.98
US$135,302 		2,880 +18.3% 46.98 US$135,302
2021-03-03 2021-03-01 S Sale
3.3
Gerritzen Daniel J

General Counsel and Secretary

Officer
2,633 -8.3%
55.85
US$147,053 		2,633 -8.3% 55.85 US$147,053
2021-03-03 2021-03-01 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
4,310 -6.3%
55.87
US$240,800 		4,310 -6.3% 55.87 US$240,800
2021-03-03 2021-03-01 S Sale
3.1
Odle Gregory A

Executive Vice President

Officer
8,193 -11.3%
55.88
US$457,825 		8,193 -11.3% 55.88 US$457,825
2021-03-03 2021-03-01 S Sale
2.6
Bailey David R

President

Officer
4,769 -5.1%
55.84
US$266,301 		4,769 -5.1% 55.84 US$266,301
2021-03-03 2021-03-01 S Sale
2.5
Throdahl Mark C

CEO

Executive Director
5,097 -3.4%
55.88
US$284,820 		5,097 -3.4% 55.88 US$284,820
2021-03-01 2021-02-25 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
699 -2.1%
57.00
US$39,843 		699 -2.1% 57.00 US$39,843
2021-02-23 2021-02-22 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
1,600 -4.6%
57.09
US$91,344 		1,600 -4.6% 57.09 US$91,344
2021-02-22 2021-02-19 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
1,701 -4.7%
57.16
US$97,229 		1,701 -4.7% 57.16 US$97,229
2021-02-22 2021-02-19 PlS Planned sale
3.1
Odle Gregory A

Executive Vice President

Officer
3,750 -4.9%
56.50
US$211,875 		3,750 -4.9% 56.50 US$211,875
Explore more

More insider trading research around OrthoPediatrics Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America